Skip to main content
Journal cover image

The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Publication ,  Journal Article
Bruyere, O; Kanis, JA; Ibar-Abadie, M-E; Alsayed, N; Brandi, ML; Burlet, N; Cahall, DL; Chines, A; Devogelaer, J-P; Dere, W; Goel, N; Korte, S ...
Published in: Osteoporos Int
May 2010

UNLABELLED: This paper provides recommendations for fair and unbiased relationship between academic scientists and the pharmaceutical industry. INTRODUCTION: Real or perceived problems in the relationship between academics and the industry have been the subject of much recent debate. It has been suggested that academic clinicians should sever all links with the industry-a view that is rarely challenged. METHODS: Academic experts and members of the pharmaceutical industry were invited to an expert consensus meeting to debate this topic. This meeting was organized by the Group for the Respect of Ethics and Excellence in Science. Conflict of interest, competing interest, right and duties of academic scientist, authorship, and staff and student education were discussed. RESULTS: Guidelines for a transparent, ethical, strong, and successful partnership between the academic scientist and the pharmaceutical industry have been provided. CONCLUSIONS: The Group support interactions between the industry and clinicians provided that it is transparent and ethical.

Duke Scholars

Published In

Osteoporos Int

DOI

EISSN

1433-2965

Publication Date

May 2010

Volume

21

Issue

5

Start / End Page

713 / 722

Location

England

Related Subject Headings

  • Trust
  • Schools, Medical
  • Interinstitutional Relations
  • Humans
  • Ethics, Research
  • Endocrinology & Metabolism
  • Education, Medical
  • Drug Industry
  • Disclosure
  • Conflict of Interest
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bruyere, O., Kanis, J. A., Ibar-Abadie, M.-E., Alsayed, N., Brandi, M. L., Burlet, N., … Reginster, J.-Y. (2010). The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporos Int, 21(5), 713–722. https://doi.org/10.1007/s00198-010-1190-9
Bruyere, O., J. A. Kanis, M. -. E. Ibar-Abadie, N. Alsayed, M. L. Brandi, N. Burlet, D. L. Cahall, et al. “The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).Osteoporos Int 21, no. 5 (May 2010): 713–22. https://doi.org/10.1007/s00198-010-1190-9.
Bruyere O, Kanis JA, Ibar-Abadie M-E, Alsayed N, Brandi ML, Burlet N, Cahall DL, Chines A, Devogelaer J-P, Dere W, Goel N, Hughes N, Kaufman J-M, Korte S, Mitlak BH, Niese D, Rizzoli R, Rovati LC, Reginster J-Y. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporos Int. 2010 May;21(5):713–722.
Journal cover image

Published In

Osteoporos Int

DOI

EISSN

1433-2965

Publication Date

May 2010

Volume

21

Issue

5

Start / End Page

713 / 722

Location

England

Related Subject Headings

  • Trust
  • Schools, Medical
  • Interinstitutional Relations
  • Humans
  • Ethics, Research
  • Endocrinology & Metabolism
  • Education, Medical
  • Drug Industry
  • Disclosure
  • Conflict of Interest